Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial

Ronald P. DeMatteo, Karla V. Ballman, Cristina R. Antonescu, Christopher Corless, Violetta Kolesnikova, Margaret Von Mehren, Martin D. McCarter, Jeffrey Norton, Robert G. Maki, Peter W T Pisters, George D. Demetri, Murray F. Brennan, Kouros Owzar

Research output: Contribution to journal › Article › peer-review

121 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences